AZTA
Price
$28.56
Change
-$0.19 (-0.66%)
Updated
Sep 26 closing price
Capitalization
1.31B
51 days until earnings call
XRAY
Price
$12.50
Change
+$0.13 (+1.05%)
Updated
Sep 26 closing price
Capitalization
2.49B
32 days until earnings call
Interact to see
Advertisement

AZTA vs XRAY

Header iconAZTA vs XRAY Comparison
Open Charts AZTA vs XRAYBanner chart's image
Azenta
Price$28.56
Change-$0.19 (-0.66%)
Volume$674.52K
Capitalization1.31B
DENTSPLY SIRONA
Price$12.50
Change+$0.13 (+1.05%)
Volume$3.98M
Capitalization2.49B
AZTA vs XRAY Comparison Chart in %
Loading...
AZTA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
XRAY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
AZTA vs. XRAY commentary
Sep 29, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AZTA is a StrongBuy and XRAY is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 29, 2025
Stock price -- (AZTA: $28.56 vs. XRAY: $12.50)
Brand notoriety: AZTA and XRAY are both not notable
Both companies represent the Pharmaceuticals: Other industry
Current volume relative to the 65-day Moving Average: AZTA: 106% vs. XRAY: 112%
Market capitalization -- AZTA: $1.31B vs. XRAY: $2.49B
AZTA [@Pharmaceuticals: Other] is valued at $1.31B. XRAY’s [@Pharmaceuticals: Other] market capitalization is $2.49B. The market cap for tickers in the [@Pharmaceuticals: Other] industry ranges from $158.13B to $0. The average market capitalization across the [@Pharmaceuticals: Other] industry is $10.82B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

AZTA’s FA Score shows that 0 FA rating(s) are green whileXRAY’s FA Score has 1 green FA rating(s).

  • AZTA’s FA Score: 0 green, 5 red.
  • XRAY’s FA Score: 1 green, 4 red.
According to our system of comparison, XRAY is a better buy in the long-term than AZTA.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

AZTA’s TA Score shows that 2 TA indicator(s) are bullish while XRAY’s TA Score has 5 bullish TA indicator(s).

  • AZTA’s TA Score: 2 bullish, 4 bearish.
  • XRAY’s TA Score: 5 bullish, 3 bearish.
According to our system of comparison, XRAY is a better buy in the short-term than AZTA.

Price Growth

AZTA (@Pharmaceuticals: Other) experienced а -8.14% price change this week, while XRAY (@Pharmaceuticals: Other) price change was -3.77% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Other industry was -1.13%. For the same industry, the average monthly price growth was -3.06%, and the average quarterly price growth was +8.48%.

Reported Earning Dates

AZTA is expected to report earnings on Nov 18, 2025.

XRAY is expected to report earnings on Oct 30, 2025.

Industries' Descriptions

@Pharmaceuticals: Other (-1.13% weekly)

Pharmaceuticals (Other) comprise companies that are involved in the discovery, development or manufacturing of therapeutic and preventative medicines. They often collaborate with or acquire other pharmaceutical/healthcare firms. Examples of companies in this segment include Bausch Health Companies Inc., Icon Plc and Perrigo Company Plc.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
XRAY($2.49B) has a higher market cap than AZTA($1.31B). XRAY YTD gains are higher at: -31.908 vs. AZTA (-42.880). XRAY has more cash in the bank: 1.27B vs. AZTA (319M). AZTA has less debt than XRAY: AZTA (52.6M) vs XRAY (2.49B).
AZTAXRAYAZTA / XRAY
Capitalization1.31B2.49B52%
EBITDA11.3MN/A-
Gain YTD-42.880-31.908134%
P/E RatioN/AN/A-
Revenue669MN/A-
Total Cash319M1.27B25%
Total Debt52.6M2.49B2%
FUNDAMENTALS RATINGS
AZTA vs XRAY: Fundamental Ratings
AZTA
XRAY
OUTLOOK RATING
1..100
1755
VALUATION
overvalued / fair valued / undervalued
1..100
71
Overvalued
4
Undervalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
9597
PRICE GROWTH RATING
1..100
8465
P/E GROWTH RATING
1..100
5084
SEASONALITY SCORE
1..100
5050

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

XRAY's Valuation (4) in the Medical Specialties industry is significantly better than the same rating for AZTA (71) in the Electronic Production Equipment industry. This means that XRAY’s stock grew significantly faster than AZTA’s over the last 12 months.

XRAY's Profit vs Risk Rating (100) in the Medical Specialties industry is in the same range as AZTA (100) in the Electronic Production Equipment industry. This means that XRAY’s stock grew similarly to AZTA’s over the last 12 months.

AZTA's SMR Rating (95) in the Electronic Production Equipment industry is in the same range as XRAY (97) in the Medical Specialties industry. This means that AZTA’s stock grew similarly to XRAY’s over the last 12 months.

XRAY's Price Growth Rating (65) in the Medical Specialties industry is in the same range as AZTA (84) in the Electronic Production Equipment industry. This means that XRAY’s stock grew similarly to AZTA’s over the last 12 months.

AZTA's P/E Growth Rating (50) in the Electronic Production Equipment industry is somewhat better than the same rating for XRAY (84) in the Medical Specialties industry. This means that AZTA’s stock grew somewhat faster than XRAY’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
AZTAXRAY
RSI
ODDS (%)
N/A
Bullish Trend 3 days ago
64%
Stochastic
ODDS (%)
Bullish Trend 3 days ago
79%
Bullish Trend 3 days ago
59%
Momentum
ODDS (%)
Bearish Trend 3 days ago
79%
Bearish Trend 3 days ago
71%
MACD
ODDS (%)
Bearish Trend 3 days ago
80%
Bearish Trend 3 days ago
61%
TrendWeek
ODDS (%)
Bearish Trend 3 days ago
80%
Bearish Trend 3 days ago
72%
TrendMonth
ODDS (%)
Bearish Trend 3 days ago
82%
Bearish Trend 3 days ago
73%
Advances
ODDS (%)
Bullish Trend 7 days ago
71%
Bullish Trend 13 days ago
58%
Declines
ODDS (%)
Bearish Trend 3 days ago
84%
Bearish Trend 4 days ago
71%
BollingerBands
ODDS (%)
N/A
Bullish Trend 3 days ago
48%
Aroon
ODDS (%)
N/A
Bullish Trend 3 days ago
55%
View a ticker or compare two or three
Interact to see
Advertisement
AZTA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
XRAY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
JVMRX30.120.31
+1.04%
JHancock Disciplined Value Mid Cap R6
BDBKX26.980.26
+0.97%
iShares Russell 2000 Small-Cap Idx K
RRRSX21.590.20
+0.94%
DWS RREEF Real Estate Securities R
LZUSX17.850.09
+0.51%
Lazard US Equity Focus Instl
MLNCX26.070.12
+0.46%
Morgan Stanley Instl Glbl Concntr C

AZTA and

Correlation & Price change

A.I.dvisor indicates that over the last year, AZTA has been loosely correlated with MTD. These tickers have moved in lockstep 65% of the time. This A.I.-generated data suggests there is some statistical probability that if AZTA jumps, then MTD could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To AZTA
1D Price
Change %
AZTA100%
-0.66%
MTD - AZTA
65%
Loosely correlated
-0.42%
RVTY - AZTA
64%
Loosely correlated
+1.23%
A - AZTA
64%
Loosely correlated
+1.23%
BRKR - AZTA
59%
Loosely correlated
+0.84%
TMO - AZTA
59%
Loosely correlated
+1.09%
More

XRAY and

Correlation & Price change

A.I.dvisor indicates that over the last year, XRAY has been loosely correlated with NVST. These tickers have moved in lockstep 55% of the time. This A.I.-generated data suggests there is some statistical probability that if XRAY jumps, then NVST could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To XRAY
1D Price
Change %
XRAY100%
+2.38%
NVST - XRAY
55%
Loosely correlated
+1.80%
QDEL - XRAY
49%
Loosely correlated
+6.76%
KIDS - XRAY
47%
Loosely correlated
+1.44%
STE - XRAY
46%
Loosely correlated
+2.00%
AZTA - XRAY
46%
Loosely correlated
-0.66%
More